8-K: OpGen Appoints David Lazar as New CEO, Announces Employment Agreement

OpGen, Inc. has appointed David Lazar as its new Chief Executive Officer, effective April 1, 2024, with a base salary of $406,000 per annum, deferred until the company has sufficient liquidity.

Summary

• OpGen, Inc. has entered into an employment agreement with David Lazar, appointing him as Chief Executive Officer, effective April 1, 2024.
• Mr. Lazar's base salary is set at $406,000 per year, but will be deferred and accrued until the company's compensation committee determines sufficient liquidity.
• The agreement includes provisions for annual incentive awards, annual bonuses, and special bonuses, including a bonus upon a change of control and for raising funds.
• The employment agreement has a three-year term with automatic one-year renewals unless either party provides notice of non-renewal.
• Mr. Lazar will also receive reimbursement for family medical coverage up to $25,000 per year.
• The agreement outlines terms for termination, including for cause, without cause, and for good reason, with specific severance packages depending on the circumstances.
• The agreement includes confidentiality, non-solicitation, and intellectual property assignment clauses.
• Disputes will be settled through arbitration administered by JAMS in San Francisco, CA.

Sentiment

Score: 4

Explanation: The appointment of a new CEO is generally positive, but the deferred salary and liquidity concerns raise significant red flags. The company's financial situation appears precarious, leading to a lower sentiment score.

Positives

• The appointment of a new CEO could bring fresh leadership and strategic direction to OpGen.
• The employment agreement includes incentives for the CEO to drive growth and value creation, such as bonuses for raising funds and a change of control.
• The agreement provides a clear framework for compensation, benefits, and termination, reducing potential future disputes.
• The inclusion of piggyback registration rights for shares issued to the CEO provides liquidity options.
• The agreement includes a clause for indemnification of the CEO to the fullest extent permitted under Delaware law.

Negatives

• The CEO's base salary is deferred until the company has sufficient liquidity, indicating potential financial challenges.
• The company's current liquidity condition is a concern, as it impacts the timing of the CEO's salary payments.
• The CEO is not obligated to certify the Annual Report on Form 10-K for the year ended December 31, 2023, which may raise concerns about the company's financial reporting.
• The CEO's employment status is that of an employee-at-will, which could lead to instability.
• The agreement includes a clause that the CEO will not be in breach for not submitting weekly timesheet reports, which may indicate a lack of focus on operational details.

Risks

• The company's liquidity issues could impact its ability to retain the CEO and execute its business plan.
• The deferred salary arrangement may create uncertainty and potential dissatisfaction for the CEO.
• The CEO's extensive history as a custodian for numerous public companies may raise questions about his long-term commitment to OpGen.
• The company's financial reporting may be subject to scrutiny due to the former CEO/CFO retaining responsibility for the 2023 annual report.
• The arbitration clause may limit the company's ability to pursue legal action against the CEO in certain circumstances.

Future Outlook

The agreement includes automatic one-year renewals of the three-year term unless either party provides written notice of non-renewal, suggesting a potential long-term commitment from both parties.

Management Comments

• The Executive shall have the customary powers, responsibilities, and authorities of CEO of corporations of the size, type and nature of the Company, as it exists from time to time.
• The Executive is not obligated to sign off on any documentation relating to the Financial Statements.
• All public announcements must be approved by the Executive, without such approval Executive may decline to provide written approval, without such approval no announcements may be disseminated.

Industry Context

The appointment of a new CEO is a significant event for a publicly traded company like OpGen, especially given the company's current liquidity challenges. The healthcare industry is competitive, and leadership changes can impact investor confidence and strategic direction.

Comparison to Industry Standards

• The base salary of $406,000 is within the range for CEOs of small to mid-sized public companies, but the deferral of the salary is unusual and indicates financial constraints.
• The incentive structure, including annual bonuses and equity awards, is common in executive compensation packages to align management interests with shareholder value.
• The special bonuses for change of control and fundraising are designed to incentivize the CEO to pursue strategic opportunities that could benefit the company.
• The inclusion of a non-solicitation clause is standard practice to protect the company's intellectual property and client relationships.
• The arbitration clause is increasingly common in employment agreements to streamline dispute resolution.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the company's liquidity and the deferred salary arrangement for the CEO.
• Employees may be affected by the company's financial challenges and potential restructuring.
• Customers may be impacted by any changes in the company's operations or product offerings.
• Suppliers may be concerned about the company's ability to pay its bills.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company needs to address its liquidity issues to ensure the CEO's salary can be paid.
• The company needs to finalize and release the 2023 annual report.
• The company may need to pursue a capital raise to fund its operations and growth initiatives.
• The company needs to ensure the new CEO is integrated into the company and is able to execute the company's strategy.

Key Dates

Keywords

CEO, employment agreement, David Lazar, executive compensation, liquidity, incentive awards, bonuses, change of control, severance, arbitration